Dec 12 (Reuters) - Antisense Therapeutics Ltd ANP.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT RELATED TO PRELIMINARY RESULTS OF CO'S ATL1102 FOR DMD PHASE II CLINICAL TRIAL
Dec 12 (Reuters) - Antisense Therapeutics Ltd ANP.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT RELATED TO PRELIMINARY RESULTS OF CO'S ATL1102 FOR DMD PHASE II CLINICAL TRIAL